Lycera Corp.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer (NCT03396497) | Lycera Corp. | 2018-08-03 |
Track Lycera Corp. automatically
Every clearance here is in the API, with alerts when new ones post.